The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21.20 - Manufacture of pharmaceutical preparations
300 jobs Number of planned job losses
Announcement Date
12 January 2023
Employment effect (start)
12 January 2023
Foreseen end date
Description
Leo Pharma, a multinational Danish manufacturer of pharmaceuticals, has announced the company will cut 300 jobs from it's Danish workforce. The restructuring is a result of the closure of their Ballerup research department which had 300 workers, including researchers, support and distribution staff. The closure of the research department is part of the company's new strategy, outsourcing innovation and research externally. Further, the future strategy for the company is to manufacture pharmaceuticals on license from other biotek companies.
Leo Pharma has a presence in more than 100 countries and employs around 1700 people in Denmark.
A previous restructuring event was recorded in the ERM Events database for Leo Pharma. In 2022, the company announced a global restructuring which will impact 1000 employees from 2022-2024 (Leo Pharma-2022-WO).
Eurofound (2023), Leo Pharma, Internal restructuring in Denmark, factsheet number 108214, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/108214.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
